HF
MGRX icon

HRT Financial’s Mangoceuticals MGRX Stock Holding History

HRT Financial’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,472
Closed -$32K – 3046
2024
Q4 		$32K Buy
+13,472
New +$35.3K ﹤0.01% 2155

Other funds holding MGRX

ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's MGRX Position: Q1 2025 in Review

HRT Financial sold out of Mangoceuticals (MGRX) in Q1 2025, closing a stake of 13,472 shares — an estimated $32K sold.

HRT Financial first reported a position in MGRX in Q4 2024 and held it in 1 quarter. The position peaked at $32K in Q4 2024. 8 funds tracked by Wall St. Rank hold MGRX as of Q1 2025.

  • HRT Financial reported no remaining Mangoceuticals position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 13,472 Mangoceuticals shares in Q1 2025, an estimated $32K.
  • HRT Financial first reported a position in Mangoceuticals in Q4 2024 and held it in 1 quarter.
  • HRT Financial's Mangoceuticals position peaked at $32K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.